Issue |
BIO Web Conf.
Volume 100, 2024
International Scientific Forum “Modern Trends in Sustainable Development of Biological Sciences” (IFBioScFU 2024)
|
|
---|---|---|
Article Number | 03001 | |
Number of page(s) | 7 | |
Section | Fundamental and Applied Research in Genetics and Molecular Biology | |
DOI | https://doi.org/10.1051/bioconf/202410003001 | |
Published online | 08 April 2024 |
ChemoProtective effects of new iodine coordinated compound in benzo[a]pyrene- induced lung cancer in BALB/c mice
1 JSC «Scientific Center for Anti-Infectious Drugs», Almaty, 050060, Kazakhstan
2 al-Farabi Kazakh National University, Almaty, 050040, Kazakhstan
* Corresponding author: asima_ashma@mail.ru
Iodine preparations are widely used in medicine as antiseptic agents. One of the new directions for the use of iodine is the prevention and therapy of certain tumor diseases, particularly breast cancer. The main mechanism of action is the induction of apoptosis. Iodine also has anti-inflammatory activity and affects the polarization of Th1/Th2 lymphocytes and M1/M2 macrophages. The newly developed iodine complex KC-144 includes both dextrin and polypeptides. In this case, lithium enhances the polarization of triiodide. We studied the acute toxicity and prophylactic activity on a model of benz(a)pyrene-induced (BaP) tumor in BALB/c mice. The average lethal dose (LD50) of KC-144 when administered orally was more than 2500 mg/kg, classifying KC-144 as a low-toxicity substance. Intraperitoneal administration of benz(a)pyrene at a dose of 100 mg/kg for two weeks induces tumor development in mice. Oral administration of KC-144 at doses of 2.5 and 25 mg/kg for one week and throughout the entire treatment period increases the lifespan of BaP-induced mice.
© The Authors, published by EDP Sciences, 2024
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.